Marc Cucurull
Institut Català d'Oncologia(ES)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, COVID-19 and healthcare impacts, Lung Cancer Diagnosis and Treatment, Peptidase Inhibition and Analysis
Most-Cited Works
- → Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study(2022)80 cited
- → Lung cancer patients with COVID-19 in Spain: GRAVID study(2021)39 cited
- → SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry(2023)33 cited
- → Targeting KRAS in Lung Cancer Beyond KRAS G12C Inhibitors: The Immune Regulatory Role of KRAS and Novel Therapeutic Strategies(2022)32 cited
- → Real-world data on T-DM1 efficacy – results of a single-center retrospective study of HER2-positive breast cancer patients(2019)24 cited
- → COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry(2022)22 cited
- → Small-Cell Lung Cancer Long-Term Survivor Patients: How to Find a Needle in a Haystack?(2021)17 cited
- → Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution(2020)17 cited
- → Correlation between PD-L1 expression and MET gene amplification in patients with advanced non-small-cell lung cancer and no other actionable oncogenic driver(2021)16 cited
- → Prognostic factors in patients with uterine sarcoma: the SARCUT study(2023)15 cited